The Future of Bio-Regeneration:

Exosome-Amino Acid Synergistic Platform

​

Bridging Pharmaceutical Science with Advanced Aesthetic Care

​

I. The Core Technology: A Multidimensional Approach

Our platform represents a paradigm shift in skin rejuvenation, moving beyond simple topical nourishment to Cellular Signaling Correction.

1. Pharmaceutical-Grade MSC Exosomes (The Signal):

   Sourced from the proprietary isolation platform, our Umbilical Cord-Derived Mesenchymal Stem Cell (MSC) Exosomes are refined using Tangential Flow Filtration (TFF). With a concentration exceeding 1*10^7 particles/mL, these nano-vesicles act as biological "messengers," delivering miRNA and growth factors directly into the cytosolic space of target fibroblasts.

2. Precision Amino Acid Homeostasis (The Fuel):

   Exosomes provide the instructions for repair, but the cell requires raw materials to execute them. Our formula integrates a complex of 15+ essential amino acids (including L-Proline, L-Glycine, and L-Lysine) optimized for Proteostasis. This provides the immediate substrate needed for the exosome-induced synthesis of Type I and Type III collagen.

3. Advanced Bio-Availability:

   Utilizing a pH-stabilized aqueous matrix, we ensure the structural integrity of the exosomal lipid bilayer, allowing for superior deep-tissue penetration compared to traditional high-molecular-weight proteins.

II. Technical Barriers & Competitive Edge

• Purity & Precision: Our exosomes undergo rigorous Nanoparticle Tracking Analysis (NTA) and Transmission Electron Microscopy (TEM) validation to ensure a uniform size distribution (typically 30-150nm), maximizing cellular uptake (Endocytosis).

• Proven Antioxidant Efficacy: Clinical benchmarks indicate a statistically significant (P < 0.05) free radical scavenging rate (DPPH), effectively neutralizing oxidative stress and blocking the pathways of photo-aging.

• Sterile Pharmaceutical Standards: Every batch is tested for mycoplasma, endotoxins, and microbial sterility, ensuring a safety profile that meets the stringent requirements of clinical-grade aesthetic procedures.

III. Clinical Benefits & Visible Outcomes

1. Accelerated Dermal Remodeling: Stimulates the "re-awakening" of dormant fibroblasts, leading to increased dermal density and a visible reduction in structural fine lines.

2. Post-Procedure Recovery: Acts as a biological "firewall" for skin barrier repair. It is the ideal companion for laser, RF, or microneedling treatments, reducing downtime by up to 50% through rapid inflammation modulation.

3. Luminous Homogeneity: By optimizing cellular turnover and metabolic health, the product achieves a "lit-from-within" transparency and a significant improvement in skin texture and tone uniformity.

IV. Partnership & Strategic Enablement

Genegobio Inc. is actively seeking to partner with Dermatology Groups, Luxury Medical Spas, and Aesthetic Device Manufacturers who are ready to transition into the era of regenerative medicine.

• Customized Formulation (OEM/ODM): We offer scalable concentrations of high-potency exosome concentrates tailored to your brand’s specific clinical objectives.

• Technical White Paper Support: Partners receive comprehensive data dossiers, including TEM imagery and safety validation, to empower your marketing and medical education teams.

• Global Logistics Buffer: Leveraging our U.S.-based headquarters, we provide secure, USD-settled procurement and cold-chain logistics for our international partners.